ProfileGDS4718 / 215604_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 92% 91% 88% 90% 92% 88% 89% 87% 89% 89% 88% 91% 85% 87% 89% 88% 86% 89% 88% 97% 89% 88% 87% 88% 92% 85% 90% 96% 91% 91% 88% 89% 91% 88% 88% 86% 91% 89% 89% 84% 89% 91% 90% 87% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.5726492
GSM549102patient 115, normal, homogenized [OPG study]9.3315291
GSM549104patient 119, normal, homogenized [OPG study]8.9619588
GSM549108patient 138, normal, homogenized [OPG study]9.1758290
GSM549119patient 077, normal, homogenized [OPG study]9.6704492
GSM549133patient 032, cancer, homogenized [OPG study]8.9269388
GSM549139patient 042, cancer, homogenized [OPG study]9.0926489
GSM549099patient 107, normal, homogenized [OPG study]8.7267687
GSM549109patient 139, normal, homogenized [OPG study]9.1233989
GSM549110patient 046, normal, homogenized [OPG study]9.1552189
GSM549114patient 063, normal, homogenized [OPG study]8.9736588
GSM549122patient 082, normal, homogenized [OPG study]9.4091991
GSM549134patient 033, cancer, homogenized [OPG study]8.4640285
GSM549136patient 036, cancer, homogenized [OPG study]8.8432787
GSM549140patient 044, cancer, homogenized [OPG study]9.0490589
GSM549111patient 047, normal, homogenized [OPG study]9.0146288
GSM549113patient 057, normal, homogenized [OPG study]8.80786
GSM549132patient 031, cancer, homogenized [OPG study]9.0656489
GSM549137patient 038, cancer, homogenized [OPG study]8.8188688
GSM549142patient 047, cancer, homogenized [OPG study]10.436297
GSM549100patient 110, normal, homogenized [OPG study]9.0402289
GSM549107patient 135, normal, homogenized [OPG study]9.0196388
GSM549115patient 068, normal, homogenized [OPG study]8.9012287
GSM549116patient 072, normal, homogenized [OPG study]9.0421588
GSM549120patient 078, normal, homogenized [OPG study]9.6508992
GSM549131patient 030, cancer, homogenized [OPG study]8.5135885
GSM549118patient 074, normal, homogenized [OPG study]9.2608690
GSM549129patient 027, cancer, homogenized [OPG study]10.258396
GSM549123patient 088, normal, homogenized [OPG study]9.4358191
GSM549124patient 006, cancer, homogenized [OPG study]9.1697791
GSM549126patient 015, cancer, homogenized [OPG study]8.8225788
GSM549128patient 025, cancer, homogenized [OPG study]9.0242689
GSM549103patient 117, normal, homogenized [OPG study]9.3516691
GSM549117patient 073, normal, homogenized [OPG study]9.0212588
GSM549138patient 041, cancer, homogenized [OPG study]8.9333288
GSM549141patient 045, cancer, homogenized [OPG study]8.6913286
GSM549130patient 028, cancer, homogenized [OPG study]9.227791
GSM549101patient 111, normal, homogenized [OPG study]9.0266989
GSM549105patient 128, normal, homogenized [OPG study]8.9708489
GSM549106patient 134, normal, homogenized [OPG study]8.4495484
GSM549112patient 048, normal, homogenized [OPG study]9.0196989
GSM549125patient 011, cancer, homogenized [OPG study]9.2479591
GSM549127patient 024, cancer, homogenized [OPG study]9.0754190
GSM549135patient 035, cancer, homogenized [OPG study]8.8697287